The reaction of 2-amino-N′-arylbenzamidines with tetracyanoethene reinvestigated: routes to imidazoles, quinazolines and quinolino[2′,3′:4,5]imidazo[1,2-c]quinazoline-8-carbonitrile

被引:4
作者
Mirallai, Styliana I. [1 ]
Manoli, Maria [1 ]
Koutentis, Panayiotis A. [1 ]
机构
[1] Univ Cyprus, Dept Chem, CY-1678 Nicosia, Cyprus
关键词
Heterocycles; Quinazolines; Imidazoles; Tetracyanoethylene; Amidines; Cyclization reactions; CARDIOTONIC AGENTS; INHIBITORS; SUBSTITUTION; AMIDINES; RECEPTOR; EGFR; 4-ARYLAMINOQUINAZOLINES; ACETYLCHOLINESTERASE; ARYLBENZAMIDINES; BENZAMIDINES;
D O I
10.1016/j.tet.2015.09.049
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
2-Amino-N'-phenylbenzamidine (1a) reacts with tetracyanoethene (TCNE) to give 2-[2-(2-aminophenyl)-5-imino-1-phenyl-1H-imidazol-4(5H)-ylidene]malononitrile (Ha), 4-(phenylamino)uinazoline-2-carbonitrile (5a) and 4-imino-3-phenyl-3,4-dihydroquinazoline-2-carbonitrile (9a). By optimizing the reaction conditions each of the compounds can be isolated as the main product and seven examples of these reactions are described. The [1H-imidazol-4(5H)-ylidene]malononitrile ha was also independently synthesized in three steps from 2-amino-N'-(2-nitrophenyl)benzamidine (25) and TCNE in an overall yield of 56%. Dimroth rearrangement of either 2-aminophenyl- or 2-nitrophenyl-substituted [1H-imidazol-4(5H)-ylidene]malononitriles ha or 27 with DBU in hot DCM gave the 2-[2-(2-aminophenyl)- and 2-[2-(2-nitrophenyl)-5-(phenylimino)-3H-imidazol-4(5H)-ylidene]malononitriles 28 (71%) and 34(59%), respectively. Treatment of the [3H-imidazol-4(5H)-ylidene]malononitrile 28 with ethyl orthoformate in DMA at 165 degrees C gave (Z)-2[3-(phenylimino)imidazo[1,2-c]quinazolin-2(3H)-ylidene]malononitrile (36) (70%), thermolysis of which gave quinolino[3',2':4,5]imidazo[1,2-c]quinazoline-13-carbonitrile (30) (97%). (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8766 / 8780
页数:15
相关论文
共 52 条
[1]   A general and a simple synthesis of {4-[(Z)-4-(arylimino)-3,4-dihydroquinazolin-2(1H)-ylidene]cyclohexa-2,5-dien-1-ylidene} malononitrile from the reaction of 2-amino-N′-arylbenzimidamides with 7,7,8,8-tetracyanoquinodimethane [J].
Abd-Elatif, Fathy F. ;
El-Shaieb, Kamal M. ;
El-Deen, Ahmed G. .
JOURNAL OF CHEMICAL RESEARCH, 2010, (08) :449-451
[2]  
Abdel-Latif F. F., 2011, J CHEM SCI, V66, P965
[3]   Synthesis of (Z)-2-(4-(arylimino)-3,4-dihydroquinazolin-2(1H)-ylidene)-1H-indene-1,3(2H)dione using 2-amino-N′-aryl-benzimidamides as a starting material [J].
Abdel-Latif, Fathy F. ;
El-Shaieb, Kamal M. ;
El-Deen, Ahmed G. .
JOURNAL OF CHEMICAL RESEARCH, 2010, (12) :699-701
[4]   SIR92 - a program for automatic solution of crystal structures by direct methods [J].
ALTOMARE, A ;
CASCARANO, G ;
GIACOVAZZO, G ;
GUAGLIARDI, A ;
BURLA, MC ;
POLIDORI, G ;
CAMALLI, M .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1994, 27 :435-435
[5]   Pyrrolidinohydroquinazolines -: a novel class of CCR3 modulators [J].
Anderskewitz, R ;
Bauer, R ;
Bodenbach, G ;
Gester, D ;
Gramlich, B ;
Morschhäuser, G ;
Birke, FW .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) :669-673
[6]  
[Anonymous], 2008, CRYSALIS CCD CRYSALI
[7]   Benzamides and benzamidines as specific inhibitors of epidermal growth factor receptor and v-Src protein tyrosine kinases [J].
Asano, T ;
Yoshikawa, T ;
Usui, T ;
Yamamoto, H ;
Yamamoto, Y ;
Uehara, Y ;
Nakamura, H .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (13) :3529-3542
[8]   Synthesis and biological evaluation of benzamides and benzamidines: structural requirement of a pyrimidine ring for inhibition of EGFR tyrosine kinase [J].
Asano, T ;
Yoshikawa, T ;
Nakamura, H ;
Uehara, Y ;
Yamamoto, Y .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) :2299-2302
[9]   Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types [J].
Baselga, J ;
Rischin, D ;
Ranson, M ;
Calvert, H ;
Raymond, E ;
Kieback, DG ;
Kaye, SB ;
Gianni, L ;
Harris, A ;
Bjork, T ;
Averbuch, SD ;
Feyereislova, A ;
Swaisland, H ;
Rojo, F ;
Albanell, J .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) :4292-4302
[10]  
BRANDENBURG K, 2006, DIAMOND VERSION 3 1